Socorro Asset Management LP Bristol Myers Squibb CO Transaction History

Socorro Asset Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $711,525 - $795,596	12,291 Added 9.3%	144,519 $8.39 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $1.91 Million - $2.12 Million	30,000 Added 29.35%	132,228 $8.46 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $416,404 - $472,296	6,337 Added 6.61%	102,228 $7.09 Million
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $428,684 - $507,623	-6,260 Reduced 6.13%	95,891 $6.9 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $2,631 - $1.56 Million	-20,245 Reduced 16.54%	102,151 $7.26 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $2.45 Million - $2.7 Million	-33,806 Reduced 21.64%	122,396 $9.42 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $61,602 - $73,867	1,002 Added 0.65%	156,202 $11.4 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $8.32 Million - $9.7 Million	155,200 New	155,200 $9.68 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Socorro Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Socorro Asset Management LP with notifications on news.